Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability

OTHER RELATED OMICS DATASETS IN: PXD001680

PROVIDER: PRJNA268911 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1685740.fastq.gz	Fastqsanger.gz
	SRR1685741.fastq.gz	Fastqsanger.gz
	SRR1685742.fastq.gz	Fastqsanger.gz
	SRR1685743.fastq.gz	Fastqsanger.gz
	SRR1685744.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Differential analysis of nucleolar proteomics in triple negative breast cancer

Project description:Breast cancer is one of the most common cancers in women. Of the different subtypes of breast cancer, the triple negative breast cancer subtype of breast cancer is the most aggressive. A proteomic screen of nucleolar content across breast cancer subtypes found that triple negative breast cancer cell lines have a distinct nucleolar proteome signature in comparison to non-TNBC breast cancer cell lines.

2021-03-05 | PXD021201 | Pride

EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer

Project description:Cancer therapeutic resistance is mediated, in part, by phenotypic heterogeneity and the plasticity of tumor cells, the latter being enabled by Epithelial-Mesenchymal Transition (EMT). However, EMT in human cancer therapeutic response remain poorly understood. We developed patient-derived organoids (PDOs) from human triple-negative breast cancer (TNBC) and investigated their response to chemotherapy. We found that chemotherapy treatment kills the bulk of tumor cells in PDOs, but there is selective survival of malignant cells that had activated an EMT program, entered a quasi-mesenchymal, stem cell-like state and display primary cilia. We developed a family of small-molecule inhibitors of ciliogenesis and show that treatment with these inhibitors, or genetic ablation of primary cilia, is sufficient to suppress this chemoresistance via NFB-induced cell death. We conclude that an EMT-ciliary signaling axis induces chemoresistance in quasi-mesenchymal stem-like cells to help tumors evade chemotherapy and represents a druggable vulnerability in human TNBC.

2025-06-30 | GSE298840 | GEO

Global phosphotyrosine survey reveals activation of multiple tyrosine kinase signaling pathways in triple negative breast cancer

Project description:About 15-20% of all breast cancers are triple negative breast cancers, which are often highly aggressive. We performed global quantitative phosphotyrosine profiling of a large panel of triple negative breast cancer cell lines using high resolution Fourier transform mass spectrometry. Our study identified 1,903 tyrosine-phosphorylated peptides derived from 969 proteins. Heterogeneous activation of tyrosine kinases was observed in triple negative breast cancer derived cell lines.

2016-07-06 | PXD001222 | Pride

Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers

Project description:Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers

| PRJNA506989 | ENA

Homo sapiens

Project description:Somatic mutations in triple negative breast cancers (TNBC) from Mexican women

| PRJNA261515 | ENA

Homo sapiens

Project description:Characterizing the heterogeneity of triple-negative breast cancers using RNA Sequencing

| PRJNA314351 | ENA

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer

Project description:This microarray dataset contains 51 triple-negative breast cancers with clinical and recurrence information for at least 3 years of follow-up and 106 luminal breast cancers (reanalyzed data from Series GSE24124, GSE9309, and GSE17040). A novel set of 45-gene signature that was statistically predictive of distant metastasis recurrence for triple-negative breast cancer was identified in this study.

2012-11-01 | GSE33926 | GEO

Homo sapiens

Project description:Molecular Characterization of Basal-like and Non-Basal-like Triple-Negative Breast Cancers

| PRJNA256987 | ENA

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer (II)

Project description:This microarray dataset contains 51 triple-negative breast cancers, 25 normal breast tissues, and 106 luminal breast cancers (reanalyzed data from Series GSE24124, GSE9309, and GSE17040). Keywords: Expression profiling by array

2014-01-02 | GSE53752 | GEO

Project description:Exome sequencing of drug-resistant Triple Negative Breast Cancers

| PRJNA1155201 | ENA